Cargando…
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins
BACKGROUND: The molecular pathology of diffuse large B cell lymphoma (DLBCL) has been extensively studied. Among DLBCL subtypes, the prognosis of CD5-positive DLBCL is worse than that of CD5-negative DLBCL, considering the central nervous system relapse and poor response to R-CHOP therapy. However,...
Autores principales: | Hiratsuka, Takuya, Ito, Shinji, Sakai, Rika, Yokose, Tomoyuki, Endo, Tatsuya, Daigo, Yataro, Miyagi, Yohei, Tsuruyama, Tatsuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498596/ https://www.ncbi.nlm.nih.gov/pubmed/37705009 http://dx.doi.org/10.1186/s12014-023-09422-z |
Ejemplares similares
-
CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancers
por: Mezawa, Yoshihiro, et al.
Publicado: (2019) -
Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma
por: Suzuki, Masaki, et al.
Publicado: (2019) -
DNAJB6b is Downregulated in Synucleinopathies
por: Folke, Jonas, et al.
Publicado: (2021) -
On the micelle formation of DNAJB6b
por: Carlsson, Andreas, et al.
Publicado: (2023) -
Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblasts
por: Mezawa, Yoshihiro, et al.
Publicado: (2023)